Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It appears to me that PTSC is facing it's "GM" moment regarding PDSG.

This investment appears to be at the crossroads regarding it's potential to ever be a viable revenue source. The product sales are extremely low relative to the over all investment that Patriot now has in the company. I suspect they haven't partnered with anyone because a) they can't find a willing partner or b) the partenership brings so little value that it doesn't warrant the hassle. It is no surprise that 47%of their sales are concentrated in customer "A" but the total sales revenue is disappointing, to say the least. This guys need to cut their losses while they can. This appears to be their "Pontiac/Hummer" moment. Time to trim the fat. IMO.

Share
New Message
Please login to post a reply